Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brentuximab Vedotin”

184 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 184 results

Testing effectiveness (Phase 2)WithdrawnNCT02623920
What this trial is testing

Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaMediastinal Large B-cell LymphomaGrey Zone Lymphoma+4 more
University of Arizona
Early research (Phase 1)Study completedNCT02822586
What this trial is testing

TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome

Who this might be right for
Mycosis FungoidesSézary Syndrome
Virginia Commonwealth University 5
Testing effectiveness (Phase 2)Looking for participantsNCT05149768
What this trial is testing

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Post-approval studies (Phase 4)Looking for participantsNCT06831370
What this trial is testing

Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Who this might be right for
Hodgkin Lymphoma
Takeda 124
Testing effectiveness (Phase 2)Study completedNCT02567851
What this trial is testing

Brentuximab Vedotin in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity

Who this might be right for
Hodgkin Disease
University of Birmingham 38
Early research (Phase 1)Study completedNCT01700751
What this trial is testing

Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, Acute MyeloidLeukemia, Lymphoblastic,AcuteMyelodysplastic Syndromes
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT03264131
What this trial is testing

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Who this might be right for
LymphomaAdult T-Cell Leukemia/LymphomaLymphatic Diseases
UNC Lineberger Comprehensive Cancer Center 16
Not applicableStudy completedNCT06295211
What this trial is testing

Brentuximab Vedotin Combined With Bendamustine Supercharge, a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma: Long-term Results of a Retrospective Monocenter Study.

Who this might be right for
Hodgkin Lymphoma
Federico II University 32
Testing effectiveness (Phase 2)Looking for participantsNCT03587844
What this trial is testing

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Who this might be right for
Mycosis FungoidesLymphomatoid PapulosisSezary Syndrome
Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01874054
What this trial is testing

Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Seagen Inc. 55
Testing effectiveness (Phase 2)Study completedNCT02505269
What this trial is testing

Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 34
Early research (Phase 1)WithdrawnNCT02780011
What this trial is testing

Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies

Who this might be right for
CD30-positive LymphomaCD30-positive Solid Tumor
Eric Bernicker, MD
Testing effectiveness (Phase 2)Study completedNCT02298283
What this trial is testing

Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD

Who this might be right for
Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 40
Not applicableLooking for participantsNCT05100056
What this trial is testing

Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma
Takeda 70
Testing effectiveness (Phase 2)UnknownNCT06201507
What this trial is testing

BV-AVD-R Treatment Children Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma
Beijing Children's Hospital 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT03712202
What this trial is testing

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage I Hodgkin LymphomaAnn Arbor Stage I Mixed Cellularity Classic Hodgkin LymphomaAnn Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma+11 more
City of Hope Medical Center 155
Testing effectiveness (Phase 2)Looking for participantsNCT04587687
What this trial is testing

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Recurrent Follicular LymphomaRefractory Follicular Lymphoma
Joseph Tuscano 23
Early research (Phase 1)Study completedNCT00430846
What this trial is testing

Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies

Who this might be right for
Lymphoma, Non-HodgkinDisease, HodgkinLymphoma, Large-Cell, Anaplastic
Seagen Inc. 45
Testing effectiveness (Phase 2)Looking for participantsNCT05039073
What this trial is testing

Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors

Who this might be right for
Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
Emory University 46
Testing effectiveness (Phase 2)UnknownNCT03652441
What this trial is testing

Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
University of Cologne 21
Load More Results